Jennifer Gilbride

Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis

Charles H. Chesnut, Arne Skag, Claus Christiansen et al. · Journal of Bone and Mineral Research · 2004 · 1.2K citations · Full text

Medicine, Pharmacotherapy, Bone Augmentation +16

Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study

Pierre D. Delmas, Robert R. Recker, C. H. Chesnut et al. · Osteoporosis International · 2004 · 279 citations

Medicine, Endocrinology, Bone Metabolism +13

A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis

Brad H. Rovin, Richard Furie, Y K Onno Teng et al. · Kidney International · 2021 · 198 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Phase <scp>III</scp>/<scp>IV</scp>, Randomized, <scp>Fifty‐Two</scp>–Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus

Ellen M. Ginzler, Luiz Sergio Guedes Barbosa, David D’Cruz et al. · Arthritis & Rheumatology · 2021 · 103 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population

Xueqing Yu, Nan Chen, Chi Chiu Mok et al. · American Journal of Kidney Diseases · 2022 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16